Decentralising Cell Therapies: How Plausible is Point-Of-Care, and How Do We Get There?

06 Sep 2023
11:00
SPONSORED BY
Adthera Bio

11:00am Chair Introduction 

Stuart Curbishley, Chief Manufacturing & Development Officer, Adthera Bio

  

11:05am Presentation: Title to be Confirmed 

  • Presentation content to be added

Dorothea Ledergerber, Chief Technical Officer, Tigen 

  

11:20am Presentation: Title to be Confirmed 

  • Presentation content to be added

Presenter to be Confirmed 

  

11:35am Presentation: Title to be Confirmed 

  • Presentation content to be added

Christian Chabannon, Head of Centre for Cell Therapy, Go CAR-T Coalition   

  

11:50am Presentation: Title to be Confirmed 

  • Presentation content to be added

Chaminda Salgado, Vice President of CMC, T-Cypher Bio 

  

12:05pm Closing Panel with Q&A 

With all session participants 

Joined by: Michal Besser, CTO, Davidoff Cancer Center, Rabin Medical Center 

 

 

Speakers

Dorothea Ledergerber
Chief Technical Officer
Tigen Pharma
Chaminda Salgado
Vice President of CMC
T-cypher Bio
Christian Chabannon
Head of Centre for Cell Therapy
GoCART Coalition
Michal Besser
CTO, Davidoff Cancer Center
Rabin Medical Center
Stuart Curbishley
Chief Manufacturing and Development Officer
Adthera Bio